DAFNA Capital Management LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1389933 LOS ANGELES, CA

Position in ALLO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,343,087

+$1,452,326 QoQ

Shares Held

1,370,118

-0.7% QoQ

Ownership

0.397%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. ALLO ranks #22 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	580,678	$56,470,935
2	DAWN	Day One Biopharmaceuticals, Inc.	978,463	$20,978,246
3	IDYA	IDEAYA Biosciences, Inc.	476,740	$15,884,976
4	XENE	Xenon Pharmaceuticals Inc.	250,772	$14,582,391
5	CYTK	Cytokinetics Inc	217,497	$14,335,227
6	NKTR	Nektar Therapeutics	165,178	$11,884,557
7	RCUS	Arcus Biosciences, Inc.	443,829	$9,586,706
8	LRMR	Larimar Therapeutics, Inc.	2,029,164	$9,131,238

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,343,087	1,370,118	-0.7%	Shares	Sole	2026-05-15
2025-12-31	$1,890,761	1,380,118	0.0%	Shares	Sole	2026-02-17
2025-09-30	$1,711,346	1,380,118	0.0%	Shares	Sole	2025-11-14
2025-06-30	$1,559,533	1,380,118	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,014,972	1,380,118	+11.3%	Shares	Sole	2025-05-15
2024-12-31	$2,641,451	1,240,118	+18.1%	Shares	Sole	2025-02-14
2024-09-30	$2,940,330	1,050,118	+73.5%	Shares	Sole	2024-11-14
2024-06-30	$1,409,883	605,100	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.